Michael Shohet, MD
Otolaryngology/Facial Plastic Surgery · New York, NYNPI 1942260815
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 100 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 21.0% — the pattern of someone who eats at a lot of different presentations.
Across 100 payments — averaging $27.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$576
- Sanofi$358
- Novartis$285
- Aerin Medical Inc.$215
- Spirair, Inc.$190
- Intersect ENT, Inc.$124
- plus $992 from 19 others
What the payments were for
- Food & beverage$2,740100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 34 | $576 |
| Sanofi | 11 | $358 |
| Novartis | 11 | $285 |
| Aerin Medical Inc. | 1 | $215 |
| Spirair, Inc. | 1 | $190 |
| Intersect ENT, Inc. | 1 | $124 |
| Acclarent, Inc | 2 | $120 |
| Grifols USA, LLC | 4 | $111 |
| Medtronic(2 entities) | 5 | $91 |
| Ionis Pharmaceuticals, Inc. | 3 | $87 |
| CSL Behring | 3 | $78 |
| Regeneron Healthcare Solutions, Inc. | 2 | $64 |
| Alk-abello, Inc | 3 | $56 |
| Optinose US, Inc. | 3 | $55 |
| Blueprint Medicines Corporation | 2 | $52 |
| Kaleo, Inc. | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 2 | $37 |
| Biocryst US Sales Co., LLC | 2 | $33 |
| Inspire Medical Systems, Inc. | 1 | $29 |
| Octapharma USA, Inc. | 1 | $26 |
| Cycle Pharmaceuticals Inc | 1 | $24 |
| Shire North American Group Inc | 1 | $17 |
| Hikma Pharmaceuticals USA | 1 | $17 |
| Stryker | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SeptAlign$380
- TURBALIGN$380
- Vivaer RF Stylus$215
- PROPEL$124
How this compares
$2,740 in reported general payments places this provider in the 60th percentile of 48 otolaryngology/facial plastic surgery providers in New York.
See all otolaryngology/facial plastic surgery providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 68 | $1,006 |
| Azelastine Hcl | 50 | $679 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 44 | $604 |
| Ipratropium Bromide | 23 | $559 |
| Famotidine | 24 | $269 |
| Mupirocin | 21 | $264 |
| Prednisone | 30 | $116 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology/facial plastic surgery in New York
- Jennifer LevineNew York$454K
- Jason MocheNew York$439K
- Stacey SilversNew York$42K
- Dara LiottaNew York$17K
- Michael PerskyNew York$3K
- Michael Bassiri TehraniNew York$2K
- Gregory DibeliusNew York$2K
- Fred LinNew York$1K
- David VolpiNew York$1K
- Lisa LiberatoreNew York$742
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.